Geng Chen
Fuzhou, 350025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Tumor immune microenvironment states inferred from TLS-associated immune-cell composition stratify prognosis in hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: February 26, 2026
Adipose tissue-derived mesenchymal stem cells combined with prednisone synergistically ameliorate autoimmune hepatitis in mice.
Journal: Stem cell research & therapy
Published: January 05, 2026
T Cell Heterogeneity Shaped by Alternative Splicing Predicts Prognosis in Hepatocellular Carcinoma.
Journal: Cancer science
Published: December 18, 2025
Implantable artificial lymph node enables rapid in vivo neoantigen-specific T-cell generation and expansion for improving antitumor immunity.
Journal: Journal for immunotherapy of cancer
Published: December 15, 2025
Sequential personalized neoantigen vaccination following first-line treatments demonstrates safety and efficacy in advanced hepatocellular carcinoma.
Journal: International journal of cancer
Published: December 08, 2025
Neoantigens and shared MICB α3 antigen dual-targeted vaccine generates potent antitumor immunity.
Journal: EMBO molecular medicine
Published: September 28, 2025
Correction: Targeted Inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 25, 2025
Spleen-targeted neoantigen mRNA vaccine induces ISG15+ CD8+ T cell-mediated tertiary lymphoid structure formation in hepatocellular carcinoma.
Journal: Cell reports. Medicine
Published: May 06, 2025
Granzyme B activated near-infrared-II ratiometric fluorescent nanoprobe for early detection of tumor response to immunotherapy.
Journal: Nature communications
Published: January 30, 2025
Targeted inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 26, 2025
Personalized neoantigen hydrogel vaccine combined with PD-1 and CTLA-4 double blockade elicits antitumor response in liver metastases by activating intratumoral CD8+CD69+ T cells.
Journal: Journal for immunotherapy of cancer
Published: November 26, 2024
Last Updated: 09/26/2026